Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

beta-Thalassemia 1Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Large Granular Lymphocytic 1Hodgkin Disease 1Hematologic Neoplasms 1Anemia, Sickle Cell 1

Interventions

Cyclophosphamide 6pembrolizumab 5fludarabine phosphate 5Vinblastine 5Nivolumab 5Granulocyte Colony-Stimulating Factor 5Filgrastim 5Doxorubicin 5Dacarbazine 5fludarabine 4Whole-Body Irradiation 4Mycophenolic Acid 4Melphalan 4Magnetic Resonance Spectroscopy 4Brentuximab Vedotin 4pegfilgrastim 3Etoposide 3Cyclosporine 3Busulfan 3Tacrolimus 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Fluorodeoxyglucose F18 2Azacitidine 2treosulfan 1tocilizumab 1thymoglobulin 1tafasitamab 1selinexor 1polatuzumab vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × thymoglobulin × 30 days × Clear all
NCT03849651 2026-06-03

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
69 enrolled 17 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡